Search Results - "TZIOUFAS, Athanasios G"

Refine Results
  1. 1
  2. 2

    Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome by Tzioufas, Athanasios G, Voulgarelis, Michael

    Published in Nature reviews. Rheumatology (01-09-2010)
    “…Sjögren's syndrome (SS) is a chronic autoimmune disorder that affects the exocrine glands, but the pathogenesis of this disease is not fully understood. This…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Treatment of rheumatoid arthritis: Unraveling the conundrum by Zampeli, Evangelia, Vlachoyiannopoulos, Panayiotis G, Tzioufas, Athanasios G

    Published in Journal of autoimmunity (01-12-2015)
    “…Abstract Rheumatoid arthritis (RA) is a heterogeneous disease with a complex and yet not fully understood pathophysiology, where numerous different cell-types…”
    Get full text
    Journal Article
  5. 5

    Clinically Significant Renal Involvement in Primary Sjögren's Syndrome: Clinical Presentation and Outcome by Goules, Andreas V., Tatouli, Ioanna P., Moutsopoulos, Haralampos M., Tzioufas, Athanasios G.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2013)
    “…Objective To estimate the prevalence and investigate the clinical features and the outcome of clinically significant renal involvement in a large cohort of…”
    Get full text
    Journal Article
  6. 6

    Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients by Papageorgiou, Aristea, Ziogas, Dimitrios C, Mavragani, Clio P, Zintzaras, Elias, Tzioufas, Athanasios G, Moutsopoulos, Haralampos M, Voulgarelis, Michael

    Published in PloS one (27-02-2015)
    “…Non-Hodgkin's lymphoma (NHL) development in Sjögren's syndrome (SS) remains a potentially lethal complication and efforts should focus on the identification of…”
    Get full text
    Journal Article
  7. 7

    COVID-19 Immunobiology: Lessons Learned, New Questions Arise by Kaklamanos, Aimilios, Belogiannis, Konstantinos, Skendros, Panagiotis, Gorgoulis, Vassilis G., Vlachoyiannopoulos, Panayiotis G., Tzioufas, Athanasios G.

    Published in Frontiers in immunology (26-08-2021)
    “…There is strong evidence that COVID-19 pathophysiology is mainly driven by a spatiotemporal immune deregulation. Both its phenotypic heterogeneity, spanning…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Classification criteria for Sjogren’s syndrome: A critical review by Baldini, Chiara, Talarico, Rosaria, Tzioufas, Athanasios G, Bombardieri, Stefano

    Published in Journal of autoimmunity (01-08-2012)
    “…Abstract Over the years, several different criteria sets have been proposed for the classification of Sjögren’s syndrome (SS), but none of them has been widely…”
    Get full text
    Journal Article Conference Proceeding
  10. 10
  11. 11

    Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjögren Syndrome by Voulgarelis, Michael, Ziakas, Panayiotis D., Papageorgiou, Aristea, Baimpa, Evangelia, Tzioufas, Athanasios G., Moutsopoulos, Haralampos M.

    Published in Medicine (Baltimore) (01-01-2012)
    “…Sjögren syndrome (SS) has been associated with the development of non-Hodgkin lymphoma (NHL). From a cohort of 584 SS patients followed in our department from…”
    Get full text
    Journal Article
  12. 12

    Topical and systemic medications for the treatment of primary Sjögren's syndrome by Ramos-Casals, Manuel, Brito-Zerón, Pilar, Sisó-Almirall, Antoni, Bosch, Xavier, Tzioufas, Athanasios G.

    Published in Nature reviews. Rheumatology (01-07-2012)
    “…Both sicca and systemic symptoms affect quality of life in patient with Sjögren's syndrome, and their management is complicated by the low level of evidence…”
    Get full text
    Journal Article
  13. 13

    Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases by Hall, John C, Casciola-Rosen, Livia, Berger, Alan E, Kapsogeorgou, Efstathia K, Cheadle, Chris, Tzioufas, Athanasios G, Baer, Alan N, Rosen, Antony

    “…Elucidating the molecular pathways active in pathologic tissues has important implications for defining disease subsets, selecting therapy, and monitoring…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases by Manolis, Antonis S, Tzioufas, Athanasios G

    Published in Current vascular pharmacology (01-01-2020)
    “…In Part 1 of this Thematic Issue entitled "Systemic Autoimmune Rheumatic Diseases and Cardiology", a panel of specialists and experts in cardiology,…”
    Get more information
    Journal Article
  16. 16

    Ablation of the Chaperone Protein ERdj5 Results in a Sjögren's Syndrome-Like Phenotype in Mice, Consistent With an Upregulated Unfolded Protein Response in Human Patients by Apostolou, Eirini, Moustardas, Petros, Iwawaki, Takao, Tzioufas, Athanasios G, Spyrou, Giannis

    Published in Frontiers in immunology (2019)
    “…Sjögren's syndrome (SS) is a chronic autoimmune disorder that affects mainly the exocrine glands. Endoplasmic reticulum (ER) stress proteins have been…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target? by Manolis, Antonis S, Tzioufas, Athanasios G

    Published in Current vascular pharmacology (01-01-2020)
    “…In the current Thematic Issue of Current Vascular Pharmacology (CVP), entitled "Systemic Autoimmune Rheumatic Diseases and Cardiology", presented in two parts,…”
    Get more information
    Journal Article
  20. 20